Empatica

Our new CE-certified Parkinson’s monitoring solution is here: EmbraceMini, a companion app & the Care Portal, powered by PKG algorithms for continuous, real-world insights and more personalized care. bit.ly/3NM4pZ4 #ParkinsonsDisease #WearableTech #MovementDisorders

A 2013 @AANmember study found an 11% shortage of neurologists in the US, projected to hit nearly 20% by 2025. There are still no disease-modifying therapies for Parkinson's. Chase Babcock & Prof. Morgante unpack the gap and where wearable tech can help: bit.ly/4wYRqEz #Parkinsons

As wearable technologies gain validation in Parkinson's disease care, the conversation is shifting from whether they work to how they can be integrated into clinical practice. Join @DrRRamdhani and Empatica's Chase Babcock on July 28. 🔗bit.ly/4y7w89j #ParkinsonsDisease #WearableTechnology

Bipolar disorder affects 40–60M people worldwide, yet diagnosis and treatment monitoring still rely on subjective assessments. Discover how EmbracePlus is helping researchers identify objective digital biomarkers to advance precision psychiatry. Read more: bit.ly/4xTYx2m @idibaps #DigitalHealth #MentalHealth

Day 2 in Basel 🇨🇭 at @Roche HQ for the 6th Annual #ClinicalTrialInnovationSummit. We're joining leaders in #clinicalresearch and trial design to discuss how #digitalbiomarkers, wearables, and real-world data are advancing clinical trials and drug development. @PanAgoraPharma

🎙️ Empatica CEO Matteo Lai will speak at the Digital Biomarkers in Clinical Trials Summit in Basel on "Building Physiological Models of Pain for Clinical Research and Patient Care." Visit our booth to see how wearable-derived #digitalbiomarkers are transforming clinical research and care. @PanAgoraPharma @Roche

We're live at SLEEP 2026 in Baltimore! 💤 Come find us at Booth #306 to see how our FDA-cleared wearables and platform are transforming sleep research and care. #SLEEP2026 #SleepResearch

We're heading to #SLEEP2026 next week! Sleep disruption is a key challenge for people with Parkinson's & epilepsy. Stop by booth #306 to see EmbraceMini, our FDA-cleared wearable for sleep monitoring 👋 #SleepMedicine #Neurology #SleepResearch

With our webinar just hours away, we're spotlighting a publication co-authored by our guest Prof. Francesca Morgante on using wrist-worn wearables to replicate the Levodopa Challenge Test in Parkinson's disease from everyday life. Join us today at 12:00 PM ET / 6:00 PM CET 🔗 bit.ly/4x7JUbt #ParkinsonsDisease #WearableTechnology #Parkinsons

We’re excited to join the Digital Breakthrough for Pharma Summit at @bmsnews, organized by @PanAgoraPharma. Our CEO Matteo Lai will discuss how to turn digital measures into regulatory-ready evidence. #DHTs

The Empatica team is heading to the World Parkinson Congress in Phoenix. Looking forward to conversations that bring together researchers, clinicians, caregivers, and people living with #Parkinsons, because meaningful progress starts by listening. #WPC2026 #ParkinsonsDisease

@sir4K_zen @DatalandMuseum Thank you, we can't wait for the grand opening!

@empatica @DatalandMuseum Ingenious blend of art and data, congrats on the Grand LA launch

We are excited to announce that @DatalandMuseum opens June 20 at The Grand LA in DTLA! We're proud to help power the technologies behind this groundbreaking museum, connecting art, architecture, and the audience within a building that dreams and remembers. Machine Dreams: Rainforest, #DATALAND’s inaugural exhibition, is an omni-sensory experience that uses data to deepen the connection between audience, machine intelligence, and the natural world. We created a custom consumer version of EmbracePlus, our FDA-cleared wearable medical device, with adapted software and algorithms that enable real-time data streaming throughout the experience. The installation evolves in response to the audience’s collective emotional state, creating a living dialogue between people and art.

Join Empatica’s Chase Babcock and Prof. Francesca Morgante to explore how continuous monitoring, wearable technology, and digital biomarkers are helping improve insights into #Parkinsons symptoms and ‘OFF’ periods beyond the clinic. 🔗Register: bit.ly/3R7KWDU

Does wearable monitoring add burden or streamline care? Prof. K. Ray Chaudhuri shared how objective data can reduce uncertainty and improve decisions. A PKG cost-effectiveness study shows fewer hospital visits and ~£14K savings per patient. 🎥bit.ly/4dw5nTs #Parkinsons

We’re recruiting participants for a usability study on a new medical wearable and companion mobile app designed to support Parkinson’s monitoring. 🎁 Thank you gift Participants will receive a $200 gift card for their time. Learn more and apply bit.ly/4u1pPBH #Wearables #WearableTech #WearableTechnology

New @GreenJournal study shows how #SUDEP awareness shapes parental grief: lack of knowledge fuels guilt, while awareness can help families process loss. We’ll be joined by two of the study’s authors to discuss why breaking the silence matters. Register ➡️bit.ly/4eQz0A4 #SUDEPAwareness #EpilepsyAwareness

As #ParkinsonsAwarenessMonth ends, the work continues. Daily symptoms often happen outside the clinic. Continuous monitoring can bring clarity between visits, helping inform better treatment and more personalized care. #Parkinsons #DigitalHealth

Hearing loss is linked to cognitive decline & dementia. New research with @EriksholmRC published in @Sciencedirect shows the EmbracePlus can predict listening effort using biomarkers, unlocking real-world endpoints in #aging & #neuroresearch bit.ly/4unh4Sh

#RCTs are essential for evaluating new treatments, yet ~20–25% are discontinued early (@JClinEpi). We surveyed researchers using EmbracePlus 👉92% achieved ≥75% completion. Better participant experience and onboarding can support sustained engagement. 🔗 bit.ly/48nHquO